How genetic differences affect cancer drug side effects

This research study is investigating how capecitabine, a commonly used tablet for treating breast, colon, stomach, and esophageal cancers, affects different people based on their genes. Specifically, researchers want to understand whether people who have a genetic variation in an enzyme called CES1 experience more side effects—particularly a painful condition called hand-foot syndrome—when taking this medication. By studying blood levels of the active cancer-fighting ingredient in the medication, the study aims to help doctors eventually personalize treatment and reduce these side effects.

Hand-foot syndrome is a common and painful side effect for some patients taking this medication, and researchers have noticed that people with certain genetic variations in the CES1 enzyme seem to experience it more often. This study exists to confirm that connection and understand the biological reason behind it, so doctors can eventually develop better strategies to prevent or manage these side effects.